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Summary. The effects  of systemic administration of dizocilpine (0.16 mg/kg, 
i.p.), clozapine (7.5 mg/kg, s.c.) and coadministration of dizocilpine (0.16rag/ 
kg, i.p.) and clozapine (7.5 mg/kg, s.c.) on acquisition of delayed alternation in 
a T-maze were tested in rats (N = 7 per group) on six days with 10 choices per 
day and  animal. Clozapine given alone did not  impair delayed alternation 
learnint, except of the first day. Dizocilpine induced a significant delayed al- 
ternation impairment on all days tested.  Pretreatment with clozapine signifi- 
cantly  improved  the  dizocilpine-induced  impairment.  Treatment-induced 
changes of delayed alternation learning and of locomotor activities showed no 
correlation. The results demonstrate that clozapine functionally compensated 
for  deficits induced by a  blockade of the N-methyl-D-asparatate (NMDA) 
subtype of glutamate receptors. 
Keywords: Clozapine, dizocilpine, glutamate, NMDA receptors,  delayed alter- 
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Introduction 
The glutamate hypothesis of schizophrenia proposed by Kim et al. (1980) and 
Kornhuber and Kornhuber (1986) postulates that a decreased glutamate trans- 
mission is involved in the pathophysiology of this disease.  In line with this 
hypothesis are findings that antagonists of the N-methyl-D-aspartate (NMDA) 
subtype of glutamate receptors as phencyclidine (PCP) or dizocilpine induce 
psychotic reactions in humans resembling those seen in schizophrenia (Allen 
and Young, 1978; Troupin et al., 1986). Furthermore intake of PCP exacerbate 
a  preexisting psychosis (Luby etal.,  1959). Hence, PCP-induced psychosis is 
regarded to  be the best pharmacological model of schizophrenia (Allen and 
Young, 1978) representing positive as well as negative symptoms (Petersen and 
Stillman, 1978). The glutamate hypothesis of schizophrenia was further cor- 224  W. Hauber 
roborated  by  observations  that  parkinsonian  patients  treated  with  the  anti- 
parkinson  drugs  amantadine  or  memantine  which  both  are  noncompetitive 
NMDA antagonists can develop psychotic  side effects (Riederer et al.,  1992). 
In postmortem tissue of patients with schizophrenia, NMDA receptor densities 
are increased in temporal and parietal cortical areas (Suga et al., 1990) and the 
putamen  (Kornhuber  et al.,  1989)  and glutamate-release is reduced in frontal 
and  temporal  cortical  tissue  (Sherman  etal.,  1991).  In  addition,  NMDA-as- 
sociated glycine binding sites are increased in schizophrenic  brains  (Ishimaru 
et al.,  1992).  These findings tentatively support  the view of a decreased gluta- 
matergic function and receptor upregulation in schizophrenia. 
In rodents NMDA antagonists induce a strong behavioural activation char- 
acterized  by  an  increased  locomotion,  stereotypy  (Clineschmidt  etal.,  1982; 
Tiedtke  etal.,  1990;  Hoffman,  1992),  turning  in  the  Ungerstedt  model  (Cli- 
neschmidt et al., 1982) and cognitive impairments leading to a deficient delayed 
alternation learning (Schmidt etal.,  1988; Hauber and Schmidt,  1990).  In ad- 
dition, prepulse inhibition of the startle response is impaired in rats with systemic 
injections of dizocilpine or PCP. Prepulse inhibition is also decreased in schizo- 
phrenic  patients  (Mansbach  and  Geyer,  1989).  The  behavioural  syndrome 
induced  by NMDA  antagonists  resembles  in  many  respects  the  behavioural 
activiation induced by dopamine agonists. However, the psychomotor activation 
due to blockade of NMDA receptors is still present in animals pretreated with 
a-methyl-paratyrosine and reserpine as shown by Carlsson and Carlsson (1989). 
There is growing evidence for interactions  between glutamatergic and do- 
paminergic systems in the basal ganglia which may be relevant for the symp- 
tomatology  and the  treatment  of schizophrenia  (see  Carlsson  and  Carlsson, 
1990; Schmidt et al., 1992 for review). Intracerebral injection of kynurenic acid, 
an unselective glutamate antagonist, or AP-5, a competitive NMDA antagonist, 
into the dorsal striatum induced locomotion and sniffing (Schmidt, 1985, 1986). 
Local infusion  of dizocilpine  or SDZ EAA 494 into  the dorsal  striatum  also 
enhanced sniffing and locomotion (Imperato et al., 1990). Inactivation of striatal 
neurons bearing NMDA receptors with the excitotoxin quinolinic acid produced 
a similar behavioural activation (Sanberg et al.,  1989; Schmidt et al.,  1988). In 
addition, intrastriatal infusion of AP-5 antagonized neuroleptic-induced  cata- 
lepsy (Yoshida et al., 1991) and in turn, intrastriatal infusion of NMDA reduced 
behavioural activities (Schmidt and Bury,  1988). Accordingly, systemically ap- 
plied NMDA was found to potentiate haloperidol-catalepsy (Mehta and Ticku, 
1990). 
Clozapine  is an atypical antipsychotic  drug and the mechanism  of action 
of this  compound  is largely unknown.  Recent  studies  showed  that clozapine 
antagonized  dizocilpine-induced  stereotypy  (Tiedtke  etal.,  1990;  Hoffman, 
1992).  Furthermore,  stereotypy induced by intrastriatal injection of AP-5 was 
antagonized  by systemic administration  of clozapine  (Schmidt,  1986).  On the 
basis of the glutamate hypothesis  of schizophrenia it was concluded  that clo- 
zapine  may  act  as  a  functional  glutamate  agonist  via  the  NMDA  receptor Clozapine and functional glutamate agonism  225 
(Schmidt, 1986, 1991). Interestingly, NMDA  was found to share ctozapine-like 
dicrimminative stimulus effects in rats (Schmidt and Volz,  1992). 
In the present study we investigated possible glutamate-mimetic effects of 
clozapine.  We  examined the  effects  of dizocilpine and  clozapine  on  delayed 
alternation learning of rats in a  T-maze, because 
I)  psychomotor stimulation due to blockade of NMDA  receptors may be 
a model of psychosis and 
II)  the delayed alternation procedure is a  sensitive task on integrity of the 
dorsal striatum (Wikmark et al., 1973) and the prefrontal cortex as well (Fuster, 
1981; Markowitsch and Pritzel, 1977). Since pathophysiology of schizophrenia 
may be related to  a  frontostriatal dyfunction (see  Robbins,  1990  for review) 
and  cortico-striatal glutamatergic neurons are  involved in regulation of psy- 
chomotor functions (Carlsson and Carlsson,  1989), this task may be especially 
appropriate. 
In our experiments we  tested the effects  of systemically administered di- 
zocilpine or clozapine and the effect of clozapine in dizocilpine-pretreated an- 
imals. Dizocilpine was used in a dose of 0.16 mg/kg which is known to produce 
a  significant impairment in this task (Schmidt et al.,  1988).  In order to assess 
a  possible effect of treatment-induced locomotor changes on learning data we 
measured the running times as an index of locomotor activity from all runs in 
the maze. 
If clozapine act as a functional glutamate agonist via NMDA receptors I)  it 
should  counteract  the  impairment  in  dizocilpine-pretreated  animals  and 
II)  when given alone it should at least theoretically even improve learning. 
Materials  and methods 
Subjects 
Subjects  used in this experiment were 28 male Sprague-Dawley rats weighing 250-300 g 
(Interfauna, Tuttlingen, FRG). Rats were housed in groups of four or five per cage and 
had free access to water. They received 12 g standard laboratory maintenance diet (Altromin, 
Lage, FRG) per day and animal. All rats were housed in a colony room maintained at 
22 4- 3 ~  on a 12:12 hours light-dark cycle (lights on 06.00h). 
Apparatus 
Delayed alternation was conducted in a T-maze which was made of plastic coated wood 
with 35 cm high walls and 20 cm wide corridors. The stem was divided by an opaque and 
manually operated guillotine door into a startbox (length:  30 cm) and a runway (length: 
60 cm). At the end of both other arms (length: 70 cm) a food cup was located. 
Behavioural  procedure 
The procedure was designed with reference to the description of Wikmark et al. (1973). 
Adaption: The animals were adapted to the maze on four days. On the first day, animals 
were left into the maze in groups of four and five for 10min. The next day, food cups in 
both arms were baited with food pellets  (45 mg; Noyes, Lancaster, U.K.), the guillotine 
door was removed and each rat was left in the maze for 5 rain.  On day three of adaption, 226  W. Hauber 
the guillotine door was introduced and an animal was repeadetly placed into the start box 
and the door was raised immediatly afterwards. The rats were trained to respond to the 
opening of the door and to enter one of the arms. 
Delayed alternation." Four randomized groups (N -- 7 per group) were used receiving 
injections with either saline,  clozapine, dizocilpine or clozapine plus dizocilpine. After the 
injection a rat was placed back into the home cage for 30 min. Thereafter a rat was tested 
in one session per day comprising 11  choices. Maze learning was tested on six days. On 
the initial choice (not scored) both arms were baited. On each of the following choices the 
animal was rewarded with one food pellet for entering the arm not visited on the previous 
run, i.e. an arm was baited until the rat responded to it. Errors were defined as successive 
choices of the same arm and were scored by video observation. The criterion for a scored 
arm entry was a complete entry in an arm with all four paws. In addition the time from 
raising the guillotine door up to an animals arrival at the food cup was measured from 
each choice and was termed here as running time. 
Drugs 
Dizocilpine ([ + ]- 5-methyl-  10,11 -dihydro-  5 H-dibenzo(a,d)cyclohepten-  5,10-imine)  (Bio- 
trend, K61n, FRG) was dissolved in physiological saline and administered intraperitoneally. 
Clozapine  (8-chloro-ll-(4-methyl-l-piperazinyl)-5H-dibenzo[b,e]-[1,4]diazepine)  (San- 
doz) was dissolved in sesame oil and administered subcutaneously in the neck region. The 
behavioural procedure was initiated 30rain after injection of either saline (1 ml/kg, i.p.), 
dizocilpine (0.16 mg/kg, i.p.),  clozapine (7.5 mg/kg, s.c.) or coadministration of clozapine 
and dizocilpine at the given doses. 
Data analysis 
The data were submitted to an analysis of variance (ANOVA) followed by an appropriate 
post hoc test for multiple comparisons of means or a T-test. For error data, a  two-way 
ANOVA with days and treatment groups as factors was calculated followed by a Tukey- 
test. The running time data were submitted to a one-way ANOVA followed by a Tukey- 
test for multiple comparisons. For simple comparisons a T-test was used. Differences were 
considered to be significant if the p-value is less then 0.05. 
Results 
A  two-way ANOVA  with  treatment  groups  and  days  as  factors  revealed a 
significant effect of treatment F(3,  126) =  71.1, p  <  0.0001,  a  significant effect 
of days F(5, 41) =  6.25, p  ~< 0.0003  as well as a  significant interaction between 
days and groups F(15,  108) =  2.32, p  <  0.0065.  A  post hoc Tukey-test showed 
that dizocilpine-treatment produced on each day a significant increase of errors 
as compared to  saline controls (p <  0.01  for each day). Clozapine-treated an- 
imals  made,  except of the  first  day  (p <  0.05),  not  more errors  than  saline- 
treated  animals.  Animals  with  injections  of clozapine  plus  dizocilpine  were, 
except of the first day (p <  0.01),  not different from saline-treated animals. A 
comparison of dizocilpine- and dizocilpine plus clozapine-treatment revealed, 
that both groups were not different on the first two days, but from the third 
day on, dizocilpine plus clozapine-treated animals made significantly less errors 
than dizocilpine-treated animals (Fig. 1). The mean running times from all days 
were  shown  for  each  treatment  group  in  Fig. 2.  A  one-way ANOVA  with Clozapine and functional glutamate agonism  227 
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Fig. 1. Mean errors (4- SEM) of groups (N = 7 for each group) treated with saline (1 ml/ 
kg, i.p.), clozapine (7.5 mg/kg., s.c.), dizocilpine (0.16 mg/kg, i.p.) and coadministration of 
clozapine and dizocilpine (at the given doses) tested for six days on acquisition of a delayed 
alternation task in a T-maze. A: dizocitpine treatment versus saline treatment (aa: p < 0.01); 
b: clozapine treatment versus saline treatment (b: p < 0.05); c: dizocilpine plus clozapine 
treatment versus saline treatment (cc: p < 0.01); d: dizocilpine treatment versus dizocilpine 
plus clozapine treatment (d: p < 0.05, dd: p < 0.01)(ANOVA  followed by Tukey's test) 
treatment as factor revealed a significant effect F(3, 1679) =  60.59, p  <  0.0001. 
A post hoc Tukey-test showed that clozapine-treated animals were signiticantly 
slower  (p <  0.01),  dizocilpine-and dizocilpine plus  clozapine-treated  animals 
significantly faster than saline treated animals (p <  0.01  and p  <  0.05). In ad- 
dition,  dizocilpine  coadministration  significantly  antagonized  the  clozapine- 
induced slowing (p <  0.01). 
In order to reveal a possible relationship between running time and errors 
we compared the mean running times of all dizocilpine-treated rats from correct 
and  incorrect  choices  of  all  days  and  found  no  significant  differences, 
t(417) =  -  0.44; p  =  0.97 (T-test) (Fig. 3). Since this within-group comparison 
may be confounded by different individual speed preferences of the animals 
and other factors, we compared the mean running times from each dizocilpine- 
treated animal in correct and incorrect choices from all days:  In none of the 
dizocilpine-treated animals a  significant difference of running times in correct 
and incorrect choices was found (not shown). We further investigated whether 
errors in ten choices from each day and  animal are a  function of the corre- 228  W.  Hauber 
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Fig. 3.  Mean  running  times  (4- SEM)  of dizocilpine-treated  animals  (N =  7)  in  correct 
(n -- 180)  and incorrect (n -- 240) choices pooled from all days (p =  0.97,  t-test) 
sponding mean running times. An analysis comprising the data from all groups 
with running time as independent and errors as dependent variable revealed no 
correlation (r =  0.0154). Within-group analysis also revealed no correlations of 
individual errors and corresponding mean running times on each day for animals 
with saline (r =  0.135),  dizocilpine (r =  0.051),  clozapine (r =  0.203)  or  dizo- 
cilpine plus clozapine injections (r =  0.17). Clozapine and functional glutamate agonism  229 
Discussion 
Systemic administration of the noncompetitive NMDA antagonist dizocilpine 
significantly impaired delayed alternation learning in rats on all days tested. 
Pretreatment with the atypical neuroleptic clozapine significantly  improved the 
dizocilpine-induced impairment on four out of six days. Clozapine when given 
alone did not alter delayed alternation learning except of the first day. 
Furthermore animals with injections of dizocilpine, clozapine and clozapine 
plus dizocilpine showed differences in their respective locomotor activities: The 
mean running times from all days were significantly reduced in dizocilpine- 
treated animals and increased in clozapine-treated animals. Clozapine antag- 
onized reduced running times in dizocilpine-pretreated animals. No correlations 
were found between treatment-induced errors in delayed alternation learning 
and changes of running times. 
As expected dizocilpine markedly impaired the acquisition of delayed al- 
ternation which replicates similar findings in a previous study (Schmidt et al., 
1988).  This result is  also in accordance with studies showing that ketamine, 
another noncompetitive NMDA antagonist, produced a similar impairment in 
the same task (Alessandri et al., 1989; Hauber and Schmidt, 1990). 
The observation that dizocilpine significantly decreased running times in 
the maze is also in line with studies showing a dizocilpine-induced increase of 
spontaneous locomotor activity (Tiedtke et al., 1990; Hoffman, 1992). Regard- 
ing  the  relationship between  errors  and corresponding running times,  both 
measures seem to be independent regardless of the treatment used here: 
I)  Dizocilpine-treated animals had the same running times in correct and 
incorrect choices. Although dizocilpine increased locomotor activity a  com- 
mitted error seems not to be a direct consequence of the increased locomotor 
activity during the corresponding choice. Thus nonspecific motor effects af- 
fecting running time such as ataxia are not causative for the observed increase 
of errors and this means in turn that clozapine's antagonistic action on errors 
is not due to a reduction of these effects. 
II)  neither in dizocilpine- nor in clozapine-, clozapine plus dizocilpine- or 
saline-treated animals a correlation of running times and errors was found. 
Therefore it is concluded that dizocitpine induced a psychomotor activation 
which is characterized by a increased locomotor activity and a cognitive im- 
pairment leading to an impaired delayed alternation learning and both processes 
seem to be independent. In line with this conclusion is the finding that ketamine 
selectively impaired acquisition of delayed alternation by naive animals, while 
retrieval of delayed alternation by ketamine-treated animals trained undrugged 
to a criterion before was intact. Thus the influence of ketamine-induced non- 
specific motor effects on impaired acquisition can be neglected, since retrieval 
remained intact in ketamine-treated animals (Hauber and Schmidt, 1989). 
To the authors knowledge this is the first study using simultaneous mea- 
surement of errors and running times in this maze task. Results show that this 230  W. Hauber 
could be a simple way to gain more information about drug-induced changes 
of locomotor behaviour and their possible effects on learning. 
Clozapine when given alone did not alter acquisition of delayed alternation, 
except  of the  first  day  on  which  a  significant  worsening  was  observed  for 
unknown reasons. Thus a cognitive enhancing effect of clozapine possibly in- 
dicative for a glutamate-agonistic effect of clozapine was not detectable in this 
task. This may have among others task-related reasons since clozapine mildly 
improved the finding of a hidden platform in the Morris water task in the same 
dose used here (Scheel-Kr/iger and Widy-Tyszkiewicz,  1990). 
Clozapine-pretreatment  significantly improved dizocilpine-induced  delayed 
alternation impairment.  In a pilot study this clozapine-dizocilpine  antagonism 
in  delayed  alternation  was  also  observed  using  the  same  dose  of clozapine 
together  with  a  lower  dose  (0.12 mg/kg)  of dizocilpine  (Hauber,  1993).  As 
already discussed, clozapine's action seems not be due to a reduction  of non- 
specific  effects,  but  to  a  reduction  of the  dizocilpine-induced  psychomotor 
activition which is characterized by a decreased locomotion  and a decrease of 
errors.  However,  clozapine  was  effective not  until  the  third  day  tested.  The 
reason for this phenomenon is not clear. The results suggest that clozapine may 
act as a functional glutamate agonist via the NMDA receptor. This view is in 
accordance with findings on a clozapine-dizocilpine antagonism in studies with 
spontaneous  behaviour  and  similarities  between  clozapine  and NMDA  in  a 
drug  discrimmination  test  (see  Introduction).  However,  Katz  and  Schmaltz 
(1981) found that not only the NMDA antagonist amantadine but also the DA 
agonist  apomorphine  induced  a  spatial  alternation  impairment  that  is char- 
acterized  by  perseveration  reflecting  an  abnormal  attentional  process.  Since 
dizocilpine stimulates DA synthesis, release and metabolism (Bubser et al., 1992; 
Imperato,  1990; Svensson et al., 1992) one may argue that deficient learning of 
delayed  alternation  is DA-dependent  and  clozapine-induced  improvement  is 
brought  about  by its  DA  receptor  blocking  properties  (see  Coward,  1992). 
However, the DA stimulating effects of dizocilpine  in the dose used here are 
weak (Rao etal.,  1990)  and behavioural  stimulation  produced  by dizocilpine 
is still present in monoamine-depleted mice pretreated with haloperidol as shown 
by Carlsson and Carlsson (1989). Besides haloperidol can lead even in low doses 
to a significant impairment of spatial learning in the Morris water task (Ploeger 
etal.,  1992).  In an 8-arm radial maze task, haloperidol  exacerbated impaired 
learning in dizocilpine-treated animals (Bischoff et al., 1988). Thus the involve- 
ment of a DA-dependent-mechanism  seems to be unlikely for the dizocilpine- 
clozapine  antagonism  in  the  task used  here  although  in  general  dizocilpine- 
induced behavioural stimulation can be mediated through dopamine-dependent 
and dopamine-independent  mechanisms (Carlsson and Carlsson,  1990). 
The integrity of the medial part of the striatum and of the prefrontal cortex 
is a prerequisite  for intact acquisition  of delayed alternation  (Wikmark et al., 
1973; Fuster,  1981; Markowitsch and Pritzel,  1977; Pisa and Cyr, 1990).  Both 
structures are anatomically linked by neurons of the prefrontal cortex projecting Clozapine and functional glutamate agonism  231 
to the medial striatum and using most probably glutamate as transmitter (Fon- 
num, 1984). Furthermore, both structures are part of a cortico-striato-thalamo- 
cortical functional loop  suggested to  mediate cognitive functions  (Alexander 
etal.,  1986).  Blockade  of NMDA  receptors  in  the  medial striatum  by  local 
infusion of the competitive NMDA  antagonist AP-5  produced a  similar im- 
pairment in the same task  as  used here (Hauber  and  Schmidt,  1989).  These 
findings suggest that NMDA  receptors in the medial striatum are one site of 
action of systemically administered dizocilpine leading to an impaired acqui- 
sition of delayed alternation.  If so clozapine may counteract dizocilpine-me- 
diated effects by a modulation of the activity of prefrontal glutamatergic neurons 
projecting to the medial striatum.  This view is in line with the glutamate hy- 
pothesis of schizophrenia. 
In summary the present finding that clozapine improved dizocilpine-induced 
impairment of delayed alternation learning suggests that this  atypical neuro- 
leptic may act as a functional glutamate agonist via the NMDA receptor. It is 
speculated that this effect may be brought about by an action within the cognitive 
cortico-striato-cortical loop. 
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